ACRO BIOMEDICAL CO., LTD. Shares Outstanding

Quick Answer

ACRO BIOMEDICAL CO., LTD. reported Shares Outstanding of 60.04 million shares for fiscal year 2025.

ACRO BIOMEDICAL CO., LTD. Shares Outstanding — Annual History

Fiscal Year Shares Outstanding YoY Change
2025 60.04M +0.0%
2024 60.04M +0.0%
2023 60.04M +0.0%
2022 60.04M +0.0%
2021 60.04M +25.7%
2020 47.76M +0.0%
2019 47.76M +0.0%
2019 47.76M +0.0%
2018 47.76M +0.2%
2017 47.66M +203.2%
2016 15.72M +0.0%
2015 15.72M

Quarterly Shares Outstanding

Quarter Ending Shares Outstanding YoY QoQ
September 30, 2025 60.04M +0.0% +0.0%
June 30, 2025 60.04M +0.0% +0.0%
March 31, 2025 60.04M +0.0% +0.0%
December 31, 2024 60.04M +0.0% +0.0%
September 30, 2024 60.04M +0.0% +0.0%
June 30, 2024 60.04M +0.0% +0.0%
March 31, 2024 60.04M +0.0% +0.0%
December 31, 2023 60.04M +0.0% +0.0%
  • ACRO BIOMEDICAL CO., LTD. showed an increase of +0.0% in Shares Outstanding compared to the prior fiscal year.
  • Over the 2015–2025 period, ACRO BIOMEDICAL CO., LTD.’s shares outstanding has grown by 281.9% (from 15.72 million shares to 60.04 million shares).
  • The most recent figure is from ACRO BIOMEDICAL CO., LTD.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 11, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment